Sight Sciences (SGHT) Retained Earnings (2020 - 2026)
Sight Sciences' (SGHT) quarterly Retained Earnings came in at -$397.7 million in Q1 2026, down 10.32% year-on-year from -$443.5 million in Q1 2025, and down 3.37% quarter-over-quarter from -$384.7 million in Q4 2025.
Sight Sciences (SGHT) Retained Earnings (2020 - 2026) Analysis & Trends
Sight Sciences' Retained Earnings history runs 7 years deep, the most recent figure standing at -$397.7 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 10.32% year-over-year to -$397.7 million in Q1 2026; TTM through Mar 2026 was -$397.7 million, a 10.32% decrease from a year earlier, with the FY2025 full-year figure at -$384.7 million, down 11.1% from the prior year.
- Retained Earnings declined to -$397.7 million in Q1 2026 per SGHT's latest filing, from -$384.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$176.3 million in Q1 2022 and bottomed at -$397.7 million in Q1 2026.
- The 5-year median for Retained Earnings is -$311.1 million (2024), against an average of -$303.3 million.
- Across the five-year window, Retained Earnings sank 66.89% in 2022 and decreased 10.32% in 2026, its largest moves.
- Year by year, Retained Earnings stood at -$239.2 million in 2022, then slipped by 23.22% to -$294.8 million in 2023, then retreated by 17.47% to -$346.3 million in 2024, then fell by 11.1% to -$384.7 million in 2025, then declined by 3.37% to -$397.7 million in 2026.
- Per Business Quant, the three latest SGHT Retained Earnings figures stand at -$397.7 million (Q1 2026), -$384.7 million (Q4 2025), and -$380.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 14.62 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -1.40 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 2.63 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | - |
| 10 | Sight Sciences | 274.03 Mn | 189.07 Mn | 16.98 Mn | -397.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -397.70 Mn |
| Dec 31, 2025 | -384.72 Mn |
| Sep 30, 2025 | -380.56 Mn |
| Jun 30, 2025 | -372.40 Mn |
| Mar 31, 2025 | -360.50 Mn |
| Dec 31, 2024 | -346.30 Mn |
| Sep 30, 2024 | -334.50 Mn |
| Jun 30, 2024 | -323.39 Mn |
| Mar 31, 2024 | -311.10 Mn |
| Dec 31, 2023 | -294.79 Mn |
| Sep 30, 2023 | -284.10 Mn |
| Jun 30, 2023 | -271.06 Mn |
| Mar 31, 2023 | -256.31 Mn |
| Dec 31, 2022 | -239.24 Mn |
| Sep 30, 2022 | -222.30 Mn |
| Jun 30, 2022 | -200.11 Mn |
| Mar 31, 2022 | -176.26 Mn |
| Dec 31, 2021 | -153.00 Mn |
| Sep 30, 2021 | -137.07 Mn |
| Jun 30, 2021 | -119.90 Mn |